HilleVax (HLVX)
(Delayed Data from NSDQ)
$1.84 USD
-0.10 (-5.15%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $1.84 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Income Statements
Fiscal Year end for HilleVax, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | NA | NA |
Cost Of Goods | 0 | 0 | 0 | NA | NA |
Gross Profit | 0 | 0 | 0 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 133 | 65 | 53 | 0 | 0 |
Income After Depreciation & Amortization | -133 | -65 | -53 | 0 | 0 |
Non-Operating Income | 12 | -91 | -46 | NA | NA |
Interest Expense | 2 | 3 | 3 | NA | NA |
Pretax Income | -124 | -160 | -102 | NA | NA |
Income Taxes | 0 | 0 | 0 | NA | NA |
Minority Interest | 0 | 0 | 0 | NA | NA |
Investment Gains/Losses | 0 | 0 | 0 | NA | NA |
Other Income/Charges | 0 | 0 | 0 | NA | NA |
Income From Cont. Operations | -124 | -160 | -102 | NA | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | NA | NA |
Net Income (GAAP) | -124 | -160 | -102 | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -134 | -65 | -53 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | NA | NA |
Income After Depreciation & Amortization | -133 | -65 | -53 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 40.60 | 27.15 | 5.62 | NA | NA |
Diluted EPS Before Non-Recurring Items | -3.04 | -5.89 | -18.22 | NA | NA |
Diluted Net EPS (GAAP) | -3.04 | -5.89 | -18.22 | NA | NA |
Fiscal Year end for HilleVax, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 49.79 | 40.29 | 33.91 | 30.18 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -49.79 | -40.29 | -33.91 | -30.18 |
Non-Operating Income | NA | 3.70 | 4.06 | 2.81 | 2.78 |
Interest Expense | NA | 0.73 | 0.73 | 0.72 | 0.50 |
Pretax Income | NA | -46.83 | -36.96 | -31.82 | -27.90 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -46.83 | -36.96 | -31.82 | -27.90 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -46.83 | -36.96 | -31.82 | -27.90 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 48.46 | 47.56 | 39.04 | 37.95 |
Diluted EPS Before Non-Recurring Items | NA | -0.97 | -0.78 | -0.81 | -0.74 |
Diluted Net EPS (GAAP) | NA | -0.97 | -0.78 | -0.81 | -0.74 |